US Patent

US10588893 — Ointment containing an oxazole compound

Composition of Matter · Assigned to Otsuka Pharmaceutical Co Ltd · Expires 2036-12-31 · 11y remaining

Vulnerability score 17/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects an ointment that stably contains an oxazole compound with specific inhibitory activity against PDE4.

USPTO Abstract

An ointment is provided. The ointment stably comprises an oxazole compound that has specific inhibitory activity against PDE4 and that is represented by the following formula (11). The ointment can be efficiently absorbed into the skin.

Drugs covered by this patent

Patent Metadata

Patent number
US10588893
Jurisdiction
US
Classification
Composition of Matter
Expires
2036-12-31
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Otsuka Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.